WebApr 13, 2024 · ReShape Lifesciences (OTCMKTS:RSLS – Get Rating) and OrthoPediatrics (NASDAQ:KIDS – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations … WebApr 11, 2024 · OTCMKTS:RSLS ReShape Lifesciences - RSLS Price Target & Analyst Ratings $2.75 +0.06 (+2.23%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $2.63 $2.87 50-Day Range $2.57 $17.04 52-Week Range $2.49 $65.00 Volume 86,606 shs Average Volume 805,389 shs Market Capitalization $1.43 million P/E Ratio N/A Dividend Yield N/A …
RSLS Price Target 2024 ReShape Lifesciences Analyst Ratings
WebMar 23, 2024 · RSLS ReShape Lifesciences Inc. Earnings Date & History +3.97% 3:59 PM 03/23/23 NASDAQ $USD Post-Market: $3.19 +0.05 (+1.59%) 7:56 PM Earnings … WebReShape Lifesciences Inc. analyst estimates, including RSLS earnings per share estimates and analyst recommendations. gatehouse llc
ReShape Lifesciences, Inc. Common Stock (RSLS) …
WebRSLS : 17.04 (+170.48%) ReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds Globe Newswire - Fri Jun 17, 2024. SAN CLEMENTE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic... WebApr 12, 2024 · Brenmiller Energy (BNRG) -19%.GlucoTrack (GCTK) -16%.Innovative Eyewear (LUCY) -16% files patent For chatGPT enabled smart eyewear.Nouveau Monde Graphite NMG -14% launches stock offering... WebReShape Lifesciences Inc. analyst estimates, including RSLS earnings per share estimates and analyst recommendations. gatehouse lock programming manual